HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease. This evidence concerns the gene HMGB1 and early-onset autosomal dominant Alzheimer disease.